Drugs / GSK2340272A
last change Jan 2011 re-read 2 minutes ago

GSK2340272A

Vaccine

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 13 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 24 trials
Phase 2 NCT01161160 Jul → Aug 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT01003418 Nov 2009 → Nov 2010 influenza GlaxoSmithKline Terminated No outcome recorded
Phase 2 NCT00971321 Sep 2009 → Nov 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00951041 Aug 2009 → Aug 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 39 trials
Phase 3 NCT01014091 Dec 2009 → Jan 2011 influenza GlaxoSmithKline Terminated No outcome recorded
Phase 3 NCT00992511 Oct 2009 → Nov 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00979407 Oct → Nov 2009 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00989287 Oct 2009 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00972517 Sep 2009 → Nov 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00975884 Sep 2009 → Apr 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00964158 Sep 2009 → Nov 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00968539 Sep 2009 → Sep 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00968526 Sep 2009 → Sep 2010 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 13 sources stand behind the page.

FieldValueCited text
Known as GSK2340272A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00971321
12

NCT00989287

NCT00964158

NCT00968539

NCT00992511

NCT00968526

NCT01161160

NCT01003418

NCT00975884

NCT00951041

NCT00979407

NCT00972517

NCT01014091

Modality Vaccine “GSK investigational vaccine GSK2340272A” NCT00951041
Route Intramuscular “Two intramuscular injections” NCT00951041